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Pathogen separation is of great signiﬁcance for precise detection and prevention of
disease outbreaks. For the ﬁrst time, protein A conjugated with chitosan-coated iron
oxide nanoparticles was prepared for pathogen separation at low concentrations from
liquid samples. Vibrio cholerae O1 (VO1) bacteria were used for testing the eﬀectiveness
of this conjugate. Transmission electron microscopy (TEM) was used to conﬁrm the
presence of captured VO1. The results showed that, after binding with a speciﬁc
antibody, the conjugate allows separation of VO1 bacteria from water samples at a
concentration as low as 10 cfu mL1. Moreover, the conjugate can be used in parallel
with conventional or modern diagnostic tests for quick and accurate detection of
pathogens.Introduction
Recently, the world has witnessed an increased number of emerging and re-
emerging infectious disease outbreaks caused by viruses and bacteria, such as
ebola, severe acute respiratory syndrome-associated coronavirus (SARS-CoV),
avian inuenza (A/H5N1, A/H7N9), foot–hand–mouth diseases, measles, diarrhea
and cholera. These outbreaks not only have public health consequences, but also
socio-economic tolls.1 Rapid and accurate detection of pathogens is of paramount
important for the control of these infectious diseases and prevention of their
spread to the community.
In particular, cholera outbreak caused by V. cholerae is one of the continuous
risks to public health and socio-economic development in many developing
countries.2 V. cholerae is a Gram-negative, comma-shaped bacterium, which
causes abrupt onset of watery diarrhoea, occasionally vomiting, renal failure,aNational Institute of Hygiene and Epidemiology, 1 Yersin Street, Hai Ba Trung District, Hanoi, Vietnam
bDepartment of Physics and Astronomy, University College London, London, WC1E 6BT, UK
cUCL Healthcare Biomagnetic and Nanomaterials Laboratories, 21 Albemarle Street, London W1S 4BS, UK.
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View Article Onlinecoma and even death. There are more than 200 known V. cholerae serogroups, but
only the O1 and O139 strains are pathogenic and cause epidemics. V. cholerae
bacteria can also live for up to one year in an aquatic environment due to a
protective bio-lm.2 It is not easy to detect V. cholerae using conventional diag-
nostic methods, because it is non-culturable and generally found in low levels in
water.3 Several techniques have been developed for detection of V. cholerae in
environmental water including immunomagnetic beads, nucleic acid-based
methods (such as PCR and DNA probe hybridization) or uorescent labeling
techniques.4 Immunomagnetic bead detection oﬀers good sensitivity, but has the
possibility of false positives. Nucleic acid-based methods require biological
agents such as primers, standardised bio-safe laboratories, and can only detect
nucleic acids rather than live bacterial cells. The uorescent labeling technique is
preferred for the detection of V. cholerae in environmental water samples, but
ltering is necessary to concentrate the bacteria from a large volume of water.
In recent years, many studies have shown the potential applications of
magnetic nanoparticles in biomedicine such as imaging, targeted drug delivery
and therapy,5 but only a few studies have used magnetic nanoparticles for the
detection of infectious disease pathogens so far.6 The main challenges in the
preparation of magnetic nanoparticles for pathogen detection are surface modi-
cation and biofunctionalisation, particularly the immobilisation of biomole-
cules on the surface of nanoparticles as probes.7
In this study, a conjugate of protein A and chitosan-coated magnetic nano-
particles was prepared for separation of V. cholerae bacteria at low concentrations
from water samples. Chitosan, a polysaccharide obtained from the N-deacetyla-
tion of chitin, is one of the most abundant polysaccharides in nature. It has been
used for a wide range of biological applications, thanks to its biocompatibility
and biodegradability.8 Its use for the functionalisation of nanoparticles not only
allows the incorporation of amine groups on the surface of the nanoparticles, but
also adds a positive charge to the system, which has been shown to be preferred
by some cell lines.9 On the other hand, protein A is well known as a molecule
which binds with high aﬃnity to the Fc region of IgG antibodies and orientates
the binding sites of the antibody molecule outwards from the surface of nano-
particles for capturing antigens.10
Herein, chitosan-coated iron oxide nanoparticles (IONPs) were rst conjugated
with protein A and then the conjugate was incubated with the specic IgG anti-
body against V. cholerae strain just before testing. The V. cholerae bacteria could
be easily magnetically separated and collected by binding to iron oxide
nanoparticles.
Experimental procedures
Materials
Protein A (PrA, extracellular from Staphylococcus aureus, lyophilized, $90%
protein basis), glutaraldehyde solution (GA, grade I, 25%), paraformaldehyde
(reagent grade), sodium cacodylate trihydrate ((CH3)2AsO2Na$3H2O, $98%), and
chitosan (C6H11NO4)n, Mw  60 000 g mol1 were obtained from Sigma Aldrich,
UK. V. cholerae O1 bacteria, anti-V. cholerae O1 polyclonal antibody, and Escher-
ichia coli (E. coli) were provided by Professor Nguyen Binh Minh and Dr Tran Huy
Hoang at Department of Bacteriology, National Institute of Hygiene and74 | Faraday Discuss., 2014, 175, 73–82 This journal is © The Royal Society of Chemistry 2014
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View Article OnlineEpidemiology (NIHE), Hanoi. Bacterial strains were inoculated at the laboratory
of enteric bacteria, certied by ISO 15189: 2012, and all proper and standard
biosafety procedure were followed when handling them. All chemicals used were
of analytical grade.
Synthesis and characterization of chitosan-coated IONPs
Chitosan-coated IOPNs were synthesized by a chemical method,11 and then
characterized by transmission electron microscope (TEM), dynamic light scat-
tering (DLS), zeta-potential (z-potential), and attenuated total reectance-Fourier
transformed infrared spectroscopy (ATR-FTIR).
Bio-conjugation of protein A to IONPs
Protein A was conjugated to the surface of chitosan-coated IONPs via a cross-
linkage with GA (Fig. 1). The two functional aldehyde groups of GA can easily co-
bind with amine groups of the chitosan layer on the surface of IONPs and those of
PrA. Firstly, the solution of chitosan-coated IONP (IONP@CHI) was diluted in
distilled water to a concentration of 10 mg mL1, and the solution pH adjusted to
pH 6.5. Next, 5% GA was added, incubated for 45 min at room temperature (RT),
and washed with phosphate-buﬀered saline, PBS (0.01 M, pH 7.4) three times to
remove residual GA (Fig. 1, step 1). 2 mg mL1 of protein A was then added to the
solution of IONPs and incubated overnight at 4 C (Fig. 1, step 2). Aer washing
twice with PBS, the non-specic binding sites on the surfaces of the nanoparticles
were blocked with 0.5% bovine serum albumin (BSA) in PBS for 20 min at RT.
Finally, the conjugate was washed with PBS twice, and then re-suspended in 0.5
mL PBS and kept at 4 C for testing. Due to the two carbonyl functional groups of
GA, as well as multiple amine groups of protein A, cross-linking could occur
between IONP@CHI leading to aggregation or precipitation; however, theseFig. 1 Step 1: Glutaraldehyde (GA) chitosan was conjugated to chitosan-coated IONP
(IONP@CHI) and step 2: reaction of IONP@CHI@GA and protein A (PrA) to form the
conjugate of IONP@CHI@GA@PrA. Step 3: preparation of IONP@CHI@GA@PrA linked
with speciﬁc antibodies against pathogens via their bio-aﬃnity.
This journal is © The Royal Society of Chemistry 2014 Faraday Discuss., 2014, 175, 73–82 | 75
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View Article Onlineagglomerates can easily be discarded. This phenomenon can easily be checked by
naked eye or using DLS to observe the increase in size of particle aggregates in the
solution. Also, round-shaped IONPs may help to minimize the eﬀect of aggrega-
tion, because there might be some free spaces remaining on the surface of each
IONP@CHI for binding to target molecules, even with several particles stuck
together. In our study, the preparation of the conjugate was done in triplicate and
no occulation was detected. The conjugate can then be incubated with specic
IgG antibodies against pathogens in advance before separation (Fig. 1, step 3).
To separate V. cholerae bacteria from a water sample, 0.5 mL of ION-
P@CHI@GA@PrA was incubated in advance with polyclonal antibody against
V. cholerae O1 at a concentration of 2 mg mL1, for 45 min at RT. In this step,
IgG antibody molecules would bind with high aﬃnity to protein A–IONPs (ION-
P@CHI@GA@PrA). A magnet was used to collect the product of IgG antibody
conjugated IONPs (IONP@CHI@GA@PrA@Ab) on the wall of the tube, washed
two times with PBS to remove unbound antibodies, and then re-suspended in
0.5 mL of PBS (Fig. 2b). This procedure can be carried out just before separation
and detection at RT in the laboratory or prepared in advance and then kept at 4 C
for further detection on-site.
Investigation of bacterial cells before testing
Scanning electron microscopy (SEM) (S-4800, Hitachi) was used to check the
presence and morphology of bacterial cells in the samples before testing with the
conjugate of IONPs and protein A. At a concentration of 106 cfumL1, the samples
of V. cholerae and E. coli were xed in 2% paraformaldehyde/2.5% GA for 1 h, then
washed with 0.1 M cacodylate buﬀer before post-xing with 2% aqueous OsO4 in
0.2 M cacodylate buﬀer for 2 h. Aer washing with 0.1 M cacodylate buﬀer again,
samples were dehydrated with increasing ethanol solutions (from 30% to 100%
with 10% increments), dried using a critical point dryer (Emitech, K850, Quorum
Technologies), and coated with Pt–Pd using ion sputter before SEM imaging.
Separation of V. cholerae O1 from water samples
V. cholerae O1 bacteria were dispersed in 0.01 M PBS (pH 7.4) with an initial
concentration of 103 cfu mL1. Ten-fold serial dilutions in water were then
prepared in test tubes to a nal volume of 5 mL from the original concentration of
bacteria. A 50 mL aliquot of the complex of IONP@CHI@GA@PrA@Ab was addedFig. 2 Separation of VO1 bacterial cells from water samples with interference factors: (a)
adding the complex of IONP@CHI@GA@PrA@Ab to the sample, and (b) attracting bacterial
cells with a bar magnet.
76 | Faraday Discuss., 2014, 175, 73–82 This journal is © The Royal Society of Chemistry 2014
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View Article Onlineto the test tube (with the ratio of 1 : 100 v/v), and mixed at RT for about 15 min
(Fig. 2a). The IONP-bound VO1 bacteria were collected on the wall of the tube
using a bar magnet, and most of the supernatant was removed with a pipette. The
conjugate was then re-suspended with the remaining water in the tube (Fig. 2b). A
drop of this solution was transferred to a carbon coated copper grid to determine
the presence of VO1 bacteria under a TEM (JEM1010, JEOL), operating at 80 kV.Results and discussion
The synthesised nanoparticles are spheroidal, as observed by TEM (Fig. 3A and B),
with an average particle size of 13.4  2.5 nm, as calculated from the measure-
ment of 400 particles (Fig. 3C). The hydrodynamic size of the chitosan-IONPs, as
observed by DLS, is 82.9  13 nm. The measured z-potential of 45 mV indicated
the presence of chitosan around the IONPs (Fig. 3D). From ATR-FTIR spectra
(Fig. 3E), we could observe the NH2 bending bands appearing at 1658 and 1588
cm1 for free chitosan, merging to the 1616 cm1 band aer coating. The peak at
1378 cm1 for the nCO vibration of the hydroxyl group, the C–N stretching at 1153
cm1 and the stretching of the aliphatic CH2 group around 2900 cm
1 were foundFig. 3 (A) and (B) TEM images of chitosan-coated IONPs and (C) particle size distribution
from image analysis obtained from the measurement of 400 particles. Size distribution
was ﬁtted with a log normal function. (D) DLS and z-potential of chitosan-IONPs and (E)
ATR-FTIR spectra of IONPs before and after chitosan coating. Reference spectrum for
chitosan is included for reference. All spectra have been normalized and oﬀset for better
comparison. The 1800–2700 cm1 range has been excluded as no signiﬁcant information
was found.
This journal is © The Royal Society of Chemistry 2014 Faraday Discuss., 2014, 175, 73–82 | 77
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View Article Onlinein the coated samples. The coordination of chitosan to the surface of the nano-
particles occurs via charge aﬃnity as the reaction occurs at acidic pH where
chitosan presents a high positive charge density and thus high aﬃnity for the
negatively charged nanoparticle surface. Nonetheless, not all the amine groups
are bound to the nanoparticles, as surface charge was 46.5 mV, due to the pres-
ence of positively charged groups. As a result, the obtained system is highly stable
due to steric repulsion of the nanoparticles provided by the polymer backbone
and the surface charge obtained from the amine groups.
Before testing with the complex of IONP@CHI@GA@PrA@Ab, the solution
containing bacterial strains was checked by SEM. SEM images revealed the
presence of V. cholerae and E. coli bacterial cells in the samples. V. cholerae
bacteria were found to be comma-shaped, measuring 0.3 mm in diameter and 1.3
mm in length and have a agellum at one cell pole (Fig. 4A). E. coli bacterial cells
are rod-shape, measuring 0.5 mm in diameter and 1.2 mm in length (Fig. 4B).
To test the eﬀectiveness of the conjugate, IONP@CHI@GA@PrA was incubated
with anti-V. cholerae O1 polyclonal antibody before being dropped into the tubes
containing V. cholerae bacteria.
The TEM images show that before the test with the complex of ION-
P@CHI@GA@PrA@Ab, V. cholerae bacterial cell could be clearly seen without the
presence of IONPs (Fig. 5a). Aer using IONP@CHI@GA@PrA@Ab to separate the
bacterial cells fromwater, V. cholerae cells were found to aggregate on the grid and
were bound by IONPs (Fig. 5b). In this study, we used polyclonal IgG antibodies
specic to V. cholerae O1 bacteria, so IONPs would specically bind around the
bacterial cell wall (Fig. 5c) as well as the bacterial agellum (Fig. 5d). All V. cholerae
O1 bacterial cells found on the grids were covered with IONPs, which demon-
strates that the capture eﬃciency of IONP@CHI@GA@PrA@Ab to V. cholerae O1
bacterial cells is up to 100%. This may be the result of the diﬀusion capacity of
IONPs in solution, as well as the specicity of the IONP@CHI@GA@PrA@Ab
complex to pathogens. By serial dilution of bacterial cultures, the results also
showed that VO1 bacteria could be detected at a level as low as 10 cfu mL1, as
indicated by the IONPs presence (repeated three times). Interestingly, most of
IONPs were found sticking around bacterial cells, with only a few small clusters of
IONPs found on the TEM grids. Aer separation, the supernatant was also
checked by TEM for the presence of bacterial cells remaining there, but none were
found on the grids. This conrmed that most of the bacterial cells adhered to
IONPs and were attracted by a magnet towards the wall of the tube.
For positive controls, the solutions containing IONP@CHI, and ION-
P@CHI@GA@PrA were incubated with V. cholerae bacteria diluted in water fromFig. 4 Scanning electron microscopic images of (A) V. cholerea and (B) E. coli.
78 | Faraday Discuss., 2014, 175, 73–82 This journal is © The Royal Society of Chemistry 2014
Fig. 5 TEM images of V. cholerae bacteria (a) before interaction with the complex of
IONP@CHI@GA@PrA@Ab, (b) aggregated and bound by IONPs, (c) IONPs bound to the
cell wall, and (d) IONPs bound to the bacterial ﬂagellum.
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View Article Onlinean initial concentration of 103 cfumL1. The same procedures used for testing the
IONP@CHI@GA@PrA@Ab complex were followed. A signicant number of
nanoparticles were found clustered on the grid, but no V. cholerae bacterial cells
were found (data not shown).
To demonstrate the specicity of the complex to the pathogens, as negative
controls E. coli bacteria were also prepared in 5 mL of PBS with an initial
concentration of 103 cfu mL1. Ten-fold serial dilutions in water were also
prepared in 5 mL for testing. The complex of IONP@CHI@GA@PrA@Ab (using
anti-V. cholerae O1 polyclonal IgG antibody) was then added to the tubes and
mixed for 15 min at RT. The same procedure used for VO1 was followed; however,
TEM images did not show the presence of E. coli bacterial cells on the grids.
Aer incubation of the protein A-conjugated IONPs with anti-V. cholerae O1
polyclonal IgG antibody, the separation ability of VO1 bacteria from water
samples could be found at concentrations as low as 10 cfu mL1, as conrmed by
TEM. More importantly, the detection level was found to be better than with
conventional diagnostic techniques, where bacterial pathogens at concentrations
lower than 102 cfu mL1 cannot be detected without inoculation, especially non-
culturable bacteria that present their own bio-lms such as V. cholerae.12
Following isolation and culture, a direct uorescent antibody (DFA) test is known
to be an eﬀective method for direct detection of V. cholerae. Hasan et al.13 applied
DFA to detect V. cholerae O139 in water samples, and the sensitivity of V. cholerae
O139 detection reached 150 cfu mL1, which was 15-fold higher than the detec-
tion levels reported here. In this work, the complex serves as a convenient and
versatile agent for separation of diﬀerent pathogens on-site or in the laboratory. It
can be used for selective enrichment of pathogens for early diagnostic tests and
preliminary pathogenic screening for a large number of patients who were
infected in a short period of time during outbreaks. Noticeably, before testing,
the samples and the complex should be adjusted to pH 7.0–7.4 to ensure
their bioactivity, but all procedures for separation and detection can be per-
formed at RT.This journal is © The Royal Society of Chemistry 2014 Faraday Discuss., 2014, 175, 73–82 | 79
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View Article OnlineThere are several reports on the preparation of magnetic nanoparticles for
pathogen detection. Gu et al.14 showed that biofunctionalised magnetic nano-
particles could capture vancomycin-resistant Enterococci and other Gram-positive
bacteria at concentrations of 10 cfu mL1 within 1 h. In this study, the authors
proposed the use of either optical microscopy or SEM to conrm the presence of
“magnetized” bacterial cells. However, to the best of our knowledge, it is very
diﬃcult to use optical microscopy to identify the diﬀerences between bacterial
strains, due to the limitation of optical resolution. On the other hand, SEM is
time-consuming, as it requires complex sample preparation by dehydration and
critical point drying steps before imaging. Gao et al.15 also prepared vancomycin-
functionalised FePt nanoparticles, but in combination with a vancomycin-
conjugated uorescent probe to detect bacteria in human blood with a response
time of 2 h. Cheng et al.16 combined biofunctional magnetic nanoparticles and
adenosine triphosphate (ATP) bioluminescence to detect E. coli inoculated into
pasteurized milk with a detection limit of 20 cfu mL1 and a detection time of
about 1 h. Recently, the development of a magneto-DNA platform based on
magnetic nanoparticles that could detect a panel of 13 bacterial species within 2 h
was reported.17 The reported literature demonstrates the use of biofunctionalised
magnetic nanoparticles for detection of diﬀerent pathogens with high sensitivity;
however, they all present some intrinsic limitations. Firstly, biofunctionalised
nanoparticles need to be prepared in advance against specic pathogens. More-
over, modern complex facilities and equipment are needed, and response time is
still longer than 1 h. It is important to consider that for magnetic nanoparticles
conjugated directly to antibodies, bio-activity may be reduced due to manipula-
tion or with time.
In this work, the conjugate of protein A and IONPs overcomes some of the
aforementioned limitations. Firstly, it serves as a convenient platform for
enrichment and separation of various pathogens in diﬀerent liquid samples, aer
just a prior incubation with their specic IgG antibodies. Moreover, this conju-
gate can be used as a smart material to selectively concentrate pathogens from a
large volume of water, which may indirectly improve the sensitivity of other
diagnostic techniques. Finally, it can also be applied for purifying water infected
by pathogens.
Concluding remarks
Our preliminary study showed that the conjugate of protein A and IONPs was
successfully prepared and tested for separation of V. cholerae bacteria at low
concentrations from water samples in the laboratory. The results showed by TEM
observation that the conjugate could easily separate V. cholerae bacteria from
water samples at concentrations as low as 10 cfu mL1. The selective separation of
specic pathogens from liquid samples is achieved by incubation of the conjugate
with a specic monoclonal or polyclonal antibody. The pathogens separated from
a large volume of liquid samples can then be detected simply by conventional
diagnostic methods or immunochromatographic strip tests on-site. More
importantly, it has the potential to be used for the separation and detection of
even unknown pathogens in clinical samples collected from emerging outbreaks.
This conjugate would be incubated in advance with serum collected from patients
presenting typical symptoms of the outbreak to perform the immunolabelling80 | Faraday Discuss., 2014, 175, 73–82 This journal is © The Royal Society of Chemistry 2014
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View Article Onlinereaction. This procedure may allow the preliminary recognition of pathogens by
studying their morphology using SEM or TEM. This approach may help other
advanced techniques to conrm the causing agent of the outbreak. Further
investigation is planned to optimize the bio-activity and stability of the conjugate
over time.Acknowledgements
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